The Current Ratio of Genetix Biotherapeutics Inc (BLUE) is
0.48.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date |
Value |
| 2024-12-31 |
0.48
|
| 2023-12-31 |
1.41
|
| 2022-12-31 |
1.56
|
| 2021-12-31 |
2.20
|
| 2020-12-31 |
5.97
|
| 2019-12-31 |
5.15
|
| 2018-12-31 |
9.69
|
| 2017-12-31 |
13.84
|
| 2016-12-31 |
9.72
|
| 2015-12-31 |
12.97
|
| Ticker |
Name |
Value |
|
MCRB
|
Seres Therapeutics, Inc.
|
2.56
|
|
BCAB
|
Bioatla Inc
|
0.37
|
|
IMGN
|
ImmunoGen Inc
|
2.49
|
|
GILD
|
Gilead Sciences, Inc.
|
1.55
|
|
LGND
|
Ligand Pharmaceuticals Incorporated
|
22.23
|
|
OLMA
|
Olema Pharmaceuticals, Inc.
|
9.95
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
4.13
|
|
RGNX
|
REGENXBIO Inc.
|
2.38
|
|
SBTX
|
Silverback Therapeutics Inc
|
17.56
|
|
950200.KQ
|
Psomagen Inc
|
1.67
|
|
CGEM
|
Cullinan Therapeutics, Inc.
|
10.25
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.90
|
|
FOLD
|
Amicus Therapeutics Inc
|
2.84
|
|
GBT
|
Global Blood Therapeutics Inc
|
9.11
|
|
QURE
|
uniQure N.V.
|
10.43
|
|
GBIO
|
Generation Bio Co
|
5.50
|
|
INO
|
Inovio Pharmaceuticals Inc
|
1.40
|
|
NRIX
|
Nurix Therapeutics, Inc.
|
7.02
|
|
SGMO
|
Sangamo Therapeutics Inc
|
0.84
|
|
AMGN
|
Amgen Inc
|
1.14
|
|
DRNA
|
Dicerna Pharmaceuticals Inc
|
3.48
|
|
KURA
|
Kura Oncology, Inc.
|
6.06
|
|
RCUS
|
Arcus Biosciences, Inc.
|
4.36
|
|
ZYME
|
Zymeworks Inc.
|
5.88
|
|
CCCC
|
C4 Therapeutics, Inc.
|
7.81
|
|
DMTK
|
DermTech Inc
|
4.59
|
|
FMTX
|
Forma Therapeutics Holdings Inc
|
13.86
|
|
MRNA
|
Moderna, Inc.
|
3.29
|
|
YMAB
|
Y-mAbs Therapeutics Inc
|
4.16
|
|
950160.KQ
|
Kolon TissueGene Inc
|
0.24
|
|
ALEC
|
Alector, Inc.
|
3.83
|
|
CYTK
|
Cytokinetics, Incorporated
|
4.53
|
|
FPRX
|
Five Prime Therapeutics Inc
|
13.18
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
1.13
|
|
MYOV
|
Myovant Sciences Ltd
|
1.95
|
|
950220.KQ
|
Neoimmunetech Inc
|
3.08
|
|
ABBV
|
AbbVie Inc.
|
0.67
|